Background: Drug development for disease modifying agents in Alzheimer’s disease (AD) is focused increasingly on targeting underlying pathology in very early stages of AD or in cognitively normal patients at elevated risk of developing dementia due to Alzheimer’s. Very early… Continue Reading →
To those interested in EXERCISE just inform you that the NEW version of VIVIFRAIL 2.0 is free available for download from here: http://www.vivifrail.com/resources (http://www.vivifrail.com/)
The contents of the JFA (Journal of Frailty & Aging) vol. 8, n° 1, 2019 are available https://link.springer.com/journal/42415/8/1
© 2025 Aging-news